Research

Fueling Discovery: Misophonia Research Fund Launches New Team Science Award, Expands 2026 Funding Opportunities, and Announces Latest Grantee Cohort

CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, announces a…

2 months ago

Springer Nature honours Indian editors at Journal Development Symposium 2025. Brings Together Leading Editors and Publishing Experts to Shape the Future of Research Integrity and AI in Scholarly Communication

NEW DELHI, Oct. 31, 2025 /PRNewswire/ -- The day long Journal Development Symposium 2025, organised by Springer Nature, brought together…

2 months ago

ITALY, ECOMONDO 2025, GLOBAL RESEARCH AND INNOVATION HUB

 From 4th to 7th November, 1.700 exhibiting brands, 350 buyers from 66 countries, 30 official delegations and 90 international associations: a global…

2 months ago

HTX Research Report Spotlights SunPerp as the Breakout Player in the 2025 Perpetual DEX Boom

PANAMA CITY, Oct. 27, 2025 /PRNewswire/ -- HTX Research, the dedicated research arm of leading global crypto exchange HTX, has…

2 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 months ago

New Benevity Impact Labs Research Reveals a Confidence Gap Among Global Grantmakers

Newly released Grants Confidence Gap Report uncovers the hidden barriers to effective corporate grantmaking October 22, 2025 13:00 ET  |…

2 months ago

World’s Leading Nutrition Researchers Discuss Future Lines of Research on Nuts and Dried Fruit at NUTS 2025

REUS, Spain, Oct. 22, 2025 /PRNewswire/ -- Leading health researchers from around the world have identified new priorities and directions…

2 months ago

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

 Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroups Berlin, Germany, October 18, 2025…

3 months ago

TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top…

3 months ago

NEW RESEARCH: Kemira Water Index 2025 exposes critical weaknesses in water resilience and alarming consumer unpreparedness

New international study led by Kemira identifies where people are most vulnerable if their community suddenly loses access to clean…

3 months ago